HER2 Support Group Forums - View Single Post - Oct 1st Press release on TDM-1

phil · 10-02-2012, 12:54 PM

65 % of pts recieving t dm-1 were still alive after 2 yrs, the lead researcher , Dr. Blackwell reports preliminary survival data as the " BEST EVER SO FAR in Her2 bc", T DM-1 is " MORE EFFECTIVE " , and " LESS TOXIC " than tyk/xel. This FDA is well into its second month of final EMILIA data analysis. ( fianl data given by Gen. approx. Aug. 24th ) Remember that they got a preliminary package of EMILIA data back in May. before ASCO. They also had the acc. apprv. data way back in 2010. ( which they rejected, shocking top bc researchers ) Watch how long they take !

10-02-2012, 12:54 PM	#2
phil Senior Member Join Date: Nov 2010 Posts: 393	Re: Oct 1st Press release on TDM-1 65 % of pts recieving t dm-1 were still alive after 2 yrs, the lead researcher , Dr. Blackwell reports preliminary survival data as the " BEST EVER SO FAR in Her2 bc", T DM-1 is " MORE EFFECTIVE " , and " LESS TOXIC " than tyk/xel. This FDA is well into its second month of final EMILIA data analysis. ( fianl data given by Gen. approx. Aug. 24th ) Remember that they got a preliminary package of EMILIA data back in May. before ASCO. They also had the acc. apprv. data way back in 2010. ( which they rejected, shocking top bc researchers ) Watch how long they take !